TY  - GEN
AU  - Smith,Kimberly Y
AU  - Patel,Parul
AU  - Fine,Derek
AU  - Bellos,Nicholaos
AU  - Sloan,Louis
AU  - Lackey,Philip
AU  - Kumar,Princy N
AU  - Sutherland-Phillips,Denise H
AU  - Vavro,Cindy
AU  - Yau,Linda
AU  - Wannamaker,Paul
AU  - Shaefer,Mark S
TI  - Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment
SN  - 1473-5571
PY  - 2009///1015
KW  - Adenine
KW  - adverse effects
KW  - Adult
KW  - Anti-HIV Agents
KW  - Antiretroviral Therapy, Highly Active
KW  - CD4 Lymphocyte Count
KW  - Cardiovascular Diseases
KW  - chemically induced
KW  - Deoxycytidine
KW  - Dideoxynucleosides
KW  - Double-Blind Method
KW  - Emtricitabine
KW  - Female
KW  - HIV Infections
KW  - drug therapy
KW  - HIV-1
KW  - genetics
KW  - Humans
KW  - Lamivudine
KW  - Lopinavir
KW  - Male
KW  - Organophosphonates
KW  - Pyrimidinones
KW  - RNA, Viral
KW  - blood
KW  - Ritonavir
KW  - Tenofovir
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/QAD.0b013e32832cbcc2
ER  -